Inside the Clinic: Updates in the Prevention and Treatment of Graft versus Host Disease - Episode 2

Incidence and Risk Factors of Acute and Chronic GVHD

March 23, 2023

Sophie Paczesny, MD, PhD , Yi-Bin Chen, MD

Dr Sophie Paczesny details the incidence of graft versus host disease (GVHD) in patients receiving allogeneic transplants, and Dr Yi-Bin Chen describes the differing risk factors for acute and chronic GVHD.

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time 0:00

EP. 1: Indications for Allogeneic Stem Cell Transplantation in the Treatment of Hematological Malignancies

Now Viewing

EP. 2: Incidence and Risk Factors of Acute and Chronic GVHD

EP. 3: Common Prophylaxis Regimens for GVHD

EP. 4: Diagnosis and Stratification of Acute and Chronic GVHD

EP. 5: Frontline Treatment Options for Acute GVHD

EP. 6: Emerging Strategies for the Treatment of Acute GVHD

EP. 7: The Importance of Early Treatment of Chronic GVHD

EP. 8: Treatment Options for Steroid-Refractory Chronic GVHD

EP. 9: Key Investigational Approaches for Acute and Chronic GVHD

EP. 10: The Evolving Field of GVHD Treatment